Medicare Enrolled

Krysta Sands, NP

Q: Does Sands receive payments from pharmaceutical companies?

Yes. Sands received a total of $2,575 from 18 companies across 25 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently Moderate for Sands) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Nurse Practitioner - Primary Care · Apopka, FL

1560 MARDEN RIDGE LOOP APT 310, Apopka, FL 32703

3862151323

Registered in NPPES since 2020

NPI: 1134755002 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Sands from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Sands? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Sands

Krysta Sands is a nurse practitioner - primary care in Apopka, FL, with 6 years of NPI registration.

Between the years covered by Open Payments, Sands received a total of $2,575 from 18 pharmaceutical and/or device companies across 25 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Sands is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years of NPI registration $2,575 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$2,575

Total received (2021-2024)

Avg $644/year across 4 years

Top 11% in FL for nurse practitioner - primary care

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$579

2023

$1,090

2022

$498

2021

$408

Payments by company (2024)

Grifols USA, LLC

$125

AstraZeneca Pharmaceuticals LP

$124

Astellas Pharma US Inc

$112

Novo Nordisk Inc

$111

Biogen, Inc.

$107

Top 3 companies account for 62.3% of 2024 payments

All-time payments by company (2021-2024) ›

Biogen, Inc.

$302

Neurocrine Biosciences, Inc.

$233

Paratek Pharmaceuticals, Inc.

$226

AstraZeneca Pharmaceuticals LP

$222

Gilead Sciences, Inc.

$196

Esperion Therapeutics, Inc.

$136

Grifols USA, LLC

$125

Shield Therapeutics Inc

$125

IDORSIA PHARMACEUTICALS US INC

$119

Salix Pharmaceuticals, a division of Bausch Health US, LLC

$114

Astellas Pharma US Inc

$112

Novo Nordisk Inc

$111

Novartis Pharmaceuticals Corporation

$106

Genentech USA, Inc.

$102

Horizon Therapeutics plc

$101

ABBVIE INC.

$89

ATRICURE, INC.

$79

Otsuka Pharmaceutical Development & Commercialization, Inc.

$77

Top 3 companies account for 29.6% of all-time payments

Associated products mentioned in payments ›

ACCRUFER · BREZTRI · CYCLOSET · Epclusa · Evrysdi · FARXIGA · INGREZZA · KRYSTEXXA · LEQVIO · NEXLIZET · NUZYRA · Prolastin-C Liquid · QUVIVIQ · SYNERGY ABLATION SYSTEM · UBRELVY · Veklury · Veozah

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for a nurse practitioner - primary care in Apopka?
Compare nurse practitioner - primary cares in the Apopka area by procedure volume, costs, and industry payment transparency.

Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse practitioner - primary cares in nearby ZIP areas

111

County median income

$77,011

Nearest hospital to ZIP centroid (approximate)

ORLANDO HEALTH-HEALTH CENTRAL HOSPITAL
5.2 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Sands is a nurse practitioner - primary care.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Sands receive payments from pharmaceutical companies?

Yes. Sands received a total of $2,575 from 18 companies across 25 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Sands) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Nurse Practitioner - Primary Cares in Apopka

Browse nurse practitioner - primary cares in Apopka ranked by procedure volume and transparency data.

Highest volume

Top Nurse Practitioner - Primary Cares in FL

Nurse practitioner - primary cares ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Nurse Practitioner - Primary Cares in FL

Which FL nurse practitioner - primary cares receive the most from drug and device companies.

By company

Biogen, Inc. Payments to Doctors

See all physicians who received payments from Biogen, Inc.

By company

Neurocrine Biosciences, Inc. Payments to Doctors

See all physicians who received payments from Neurocrine Biosciences, Inc.

By company

Paratek Pharmaceuticals, Inc. Payments to Doctors

See all physicians who received payments from Paratek Pharmaceuticals, Inc.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology